Clobetasol

Common brands: Impoyz, Clodan, Clobetasol Propionate (Emollient), Byqlovi, Clobetasol Propionate Anda

Top reporter: Primus Pharmaceuticals, Inc.

Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Interleukin-4 Receptor alpha Antagonist [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
9,815
Total Reports
5,470
Serious Reports
431
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.39%)

Patient Demographics

Male
3,151
Female
5,602

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Clobetasol.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 1,037
9.0%
2 PRURITUS 819
7.1%
3 OFF LABEL USE 652
5.7%
4 RASH 606
5.3%
5 PSORIASIS 538
4.7%
6 FATIGUE 490
4.3%
7 PRODUCT USE IN UNAPPROVED INDICATION 487
4.2%
8 HEADACHE 467
4.1%
9 NAUSEA 420
3.7%
10 DIARRHOEA 415
3.6%
11 ARTHRALGIA 388
3.4%
12 PAIN 381
3.3%
13 SKIN EXFOLIATION 349
3.0%
14 DRY SKIN 347
3.0%
15 ERYTHEMA 324
2.8%
16 CONDITION AGGRAVATED 316
2.8%
17 PRODUCT DOSE OMISSION ISSUE 299
2.6%
18 DYSPNOEA 292
2.5%
19 INJECTION SITE PAIN 279
2.4%
20 DERMATITIS ATOPIC 268
2.3%
21 DIZZINESS 267
2.3%
22 PAIN IN EXTREMITY 266
2.3%
23 FALL 245
2.1%
24 ECZEMA 240
2.1%
25 VOMITING 226
2.0%
26 PYREXIA 221
1.9%
27 INSOMNIA 219
1.9%
28 MALAISE 219
1.9%
29 ASTHENIA 202
1.8%
30 WEIGHT DECREASED 198
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.